FDA’s Regulations on “Intended Use”: One More Try
By: Daniel Dwyer On September 23, 2020, FDA published a proposed rule that would amend its medical product “intended use” regulations. This … more
By: Daniel Dwyer On September 23, 2020, FDA published a proposed rule that would amend its medical product “intended use” regulations. This … more
KKB Partner KS Reagan will be speaking at the American Conference Institute (ACI) FDA Boot Camp on September 23, 2020. Mr. Reagan’s presentation, “Navigating the Approval … more
KKB Partner Stacy Ehrlich will be speaking at the closing panel of the Global Tobacco & Nicotine Forum (GTNF) annual conference on September 24, … more
KKB Partner Cynthia L. Meyer will be speaking at the Food and Drug Law Institute’s (FDLI’s) Food Advertising, Labeling, and Litigation Conference on September 22, 2020. … more
KKB Partner Suzan Onel will be speaking at the Food and Drug Law Institute’s Virtual Digital Health Technology and Regulation During COVID-19 and … more
We are proud to announce that nine Kleinfeld, Kaplan and Becker, LLP, partners have been recognized in “Best Lawyers in America.” Information … more
KKB Partner Jacqueline J. Chan will lead a discussion on the labeling of plant-based foods as part of FDLI’s Law Over Lunch … more
By: Cynthia L. Meyer, Jacqueline J. Chan, and T. Daniel Logan (An edited version of this article was published in Law360 on … more
By: Suzan Onel, Cynthia L. Meyer, and Justine E. Lenehan See our later Insight published July 6, 2021, related to FDA’s revocation … more
By: Daniel Dwyer, Jacqueline Chan, and Vanessa Fulton On May 22, 2020, FDA issued a guidance document providing temporary flexibility for certain … more